{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:48:15Z","timestamp":1792896495623,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00210-024-03071-1","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T08:01:47Z","timestamp":1712044907000},"page":"6855-6866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparing the toxicity effects of copper oxide nanoparticles conjugated with Lapatinib on breast (MDA-MB-231) and lung (A549) cancer cell lines"],"prefix":"10.1007","volume":"397","author":[{"given":"Masoumeh Valizadeh","family":"Talarposhti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salehzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"issue":"1","key":"3071_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jcis.2008.11.048","volume":"331","author":"F Adam","year":"2009","unstructured":"Adam F, Osman H, Hello KM (2009) The immobilization of 3-(chloropropyl) triethoxysilane onto silica by a simple one-pot synthesis. J Colloid Interface Sci 331(1):143\u2013147","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"3071_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)00010-6","volume":"102","author":"R Agami","year":"2000","unstructured":"Agami R, Bernards R (2000) Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102(1):55\u201366. https:\/\/doi.org\/10.1016\/S0092-8674(00)00010-6","journal-title":"Cell"},{"issue":"Pt A","key":"3071_CR3","doi-asserted-by":"publisher","first-page":"121163","DOI":"10.1016\/j.lfs.2022.121163","volume":"311","author":"SM Akram","year":"2022","unstructured":"Akram SM, Al-Saffar AZ, Hadi NA, Akram SM (2022) Utilization of novel lectin-conjugated Au nanoparticles as Thomsen-Friedenreich onco-antigen target for in vitro cytotoxicity and apoptosis induction in leukemic cell line. Life Sci 311(Pt A):121163. https:\/\/doi.org\/10.1016\/j.lfs.2022.121163","journal-title":"Life Sci"},{"key":"3071_CR4","doi-asserted-by":"publisher","unstructured":"Barnum KJ, O\u2019Connell MJ (2014) Cell cycle regulation by checkpoints. In: Noguchi E, Gadaleta MC (eds) Cell cycle control,\u00a0vol 1170.\u00a0Springer, New York, pp 29\u201340.\u00a0https:\/\/doi.org\/10.1007\/978-1-4939-0888-2_2","DOI":"10.1007\/978-1-4939-0888-2_2"},{"key":"3071_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtemb.2016.02.006","volume":"35","author":"M Bost","year":"2016","unstructured":"Bost M, Houdart S, Oberli M, Kalonji E, Huneau JF, Margaritis I (2016) Dietary copper and human health: Current evidence and unresolved issues. J Trace Elem Med Biol 35:107\u2013115. https:\/\/doi.org\/10.1016\/j.jtemb.2016.02.006","journal-title":"J Trace Elem Med Biol"},{"issue":"2","key":"3071_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5185\/amlett.2015.5656","volume":"6","author":"N Bouazizi","year":"2015","unstructured":"Bouazizi N, Bargougui R, Oueslati A, Benslama R (2015) Effect of synthesis time on structural, optical and electrical properties of CuO nanoparticles synthesized by reflux condensation method. Adv Mater Lett 6(2):158\u2013164","journal-title":"Adv Mater Lett"},{"issue":"6","key":"3071_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cbin.11137","volume":"43","author":"MS D\u2019arcy","year":"2019","unstructured":"D\u2019arcy MS (2019) Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 43(6):582\u2013592. https:\/\/doi.org\/10.1002\/cbin.11137","journal-title":"Cell Biol Int"},{"key":"3071_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molmet.2019.11.011","volume":"33","author":"J Garcia-Bermudez","year":"2020","unstructured":"Garcia-Bermudez J, Williams RT, Guarecuco R, Birsoy K (2020) Targeting extracellular nutrient dependencies of cancer cells. Molecular Metabolism 33:67\u201382. https:\/\/doi.org\/10.1016\/j.molmet.2019.11.011","journal-title":"Molecular Metabolism"},{"key":"3071_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/jnci\/djn216","volume":"100","author":"B Gril","year":"2008","unstructured":"Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L, Liewehr DJ, Steinberg SM, Merino MJ, Rubin SD, Steeg PS (2008) Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 100:1092\u20131103. https:\/\/doi.org\/10.1093\/jnci\/djn216","journal-title":"J Natl Cancer Inst"},{"key":"3071_CR10","doi-asserted-by":"publisher","unstructured":"Hajializadeh D, Saber AA, Jameh M, Ahang B, Moafy A, Bijarpas ZK, ... Salehzadeh A (2023) Potential of apoptosis-inducing by a novel bio-synthesized CoFe2O4@ Ag nanocomposite in gastric cell line at the cellular and molecular level. J Clust Sci 34(1):359\u2013371. https:\/\/doi.org\/10.1007\/s10876-022-02228-3","DOI":"10.1007\/s10876-022-02228-3"},{"issue":"9","key":"3071_CR11","doi-asserted-by":"publisher","first-page":"e22973","DOI":"10.1371\/journal.pone.0022973","volume":"6","author":"AB Herman","year":"2011","unstructured":"Herman AB, Savage VM, West GB (2011) A quantitative theory of solid tumor growth, metabolic rate and vascularization. PLoS One 6(9):e22973. https:\/\/doi.org\/10.1371\/journal.pone.0022973","journal-title":"PLoS ONE"},{"key":"3071_CR12","doi-asserted-by":"publisher","unstructured":"Hosseinkhah M, Ghasemian R, Shokrollahi F, Mojdehi SR, Noveiri MJS, Hedayati M, ... Salehzadeh A (2021) Cytotoxic potential of nickel oxide nanoparticles functionalized with glutamic acid and conjugated with thiosemicarbazide (NiO@ Glu\/TSC) against human gastric cancer cells. J Clust Sci 1\u20139. https:\/\/doi.org\/10.1007\/s10876-021-02124-2","DOI":"10.1007\/s10876-021-02124-2"},{"key":"3071_CR13","doi-asserted-by":"publisher","unstructured":"Jarestan M, Khalatbari K, Pouraei A, Sadat Shandiz SA, Beigi S, Hedayati M, ... Salehzadeh A (2020). Preparation, characterization, and anticancer efficacy of novel cobalt oxide nanoparticles conjugated with thiosemicarbazide. 3 Biotech 10:1\u20139. https:\/\/doi.org\/10.1007\/s13205-020-02230-4","DOI":"10.1007\/s13205-020-02230-4"},{"key":"3071_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.suronc.2011.01.001","volume":"21","author":"K Jha","year":"2012","unstructured":"Jha K, Shukla M, Pandey M (2012) Survivin expression and targeting in breast cancer. Surg Oncol 21:125\u2013131. https:\/\/doi.org\/10.1016\/j.suronc.2011.01.001","journal-title":"Surg Oncol"},{"key":"3071_CR15","doi-asserted-by":"publisher","unstructured":"Kalaiarasi A, Sankar R, Anusha C, Saravanan K, Aarthy K, Karthic S, ... Ravikumar V (2018) Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylase. Biotechnol Lett 40:249\u2013256. https:\/\/doi.org\/10.1007\/s10529-017-2463-6","DOI":"10.1007\/s10529-017-2463-6"},{"key":"3071_CR16","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.2147\/IJN.S406415","volume":"18","author":"SJ Kim","year":"2023","unstructured":"Kim SJ, Puranik N, Yadav D, Jin JO, Lee PCW (2023) Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer. Int J Nanomed 18:2659\u20132676. https:\/\/doi.org\/10.2147\/IJN.S406415","journal-title":"Int J Nanomed"},{"key":"3071_CR17","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-05-1182","volume":"66","author":"GE Konecny","year":"2006","unstructured":"Konecny GE, Pegram MD, Venkatesan N, Finn R, Yang G, Rahmeh M, Untch M, Rusnak DW, Spehar G, Mullin RJ, Keith BR, Gilmer TM, Berger M, Podratz KC, Slamon DJ (2006) Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. Can Res 66:1630\u20131639. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1182","journal-title":"Can Res"},{"issue":"1","key":"3071_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00775-019-01729-3","volume":"25","author":"R Kumari","year":"2020","unstructured":"Kumari R, Saini AK, Kumar A, Saini RV (2020) Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction. J Biol Inorg Chem 25(1):23\u201337. https:\/\/doi.org\/10.1007\/s00775-019-01729-3","journal-title":"J Biol Inorg Chem"},{"key":"3071_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ijbiomac.2021.06.144","volume":"184","author":"RI Mahmood","year":"2021","unstructured":"Mahmood RI, Abbass AK, Razali N, Al-Saffar AZ, Al-Obaidi JR (2021) Protein profile of MCF-7 breast cancer cell line treated with lectin delivered by CaCO3NPs revealed changes in molecular chaperones, cytoskeleton, and membrane-associated proteins. Int J Biol Macromol 184:636\u2013647. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.144","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3071_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40089-022-00380-2","volume":"12","author":"M Maliki","year":"2022","unstructured":"Maliki M, Ifijen IH, Ikhuoria EU, Jonathan EM, Onaiwu GE, Archibong UD, Ighodaro A (2022) Copper nanoparticles and their oxides: optical, anticancer and antibacterial properties. Int Nano Lett 12(4):379\u2013398. https:\/\/doi.org\/10.1007\/s40089-022-00380-2","journal-title":"Int Nano Lett"},{"issue":"4","key":"3071_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.bbamcr.2010.08.011","volume":"1813","author":"EF Mason","year":"2011","unstructured":"Mason EF, Rathmell JC (2011) Cell metabolism: an essential link between cell growth and apoptosis. Biochimica et Biophysica Acta (BBA) Mol Cell Res 1813(4):645\u2013654. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.08.011","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Cell Res"},{"issue":"3","key":"3071_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ijrobp.2003.09.093","volume":"58","author":"RD Mass","year":"2004","unstructured":"Mass RD (2004) The HER receptor family: a rich target for therapeutic development. Int J Radiat Oncol Biol Phys 58(3):932\u2013940. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.09.093","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3071_CR23","doi-asserted-by":"publisher","unstructured":"Medici S, Peana M, Pelucelli A, Zoroddu MA (2021) An updated overview on metal nanoparticles toxicity. In Seminars in Cancer Biology (Vol. 76, pp. 17\u201326). Academic Press. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.020","DOI":"10.1016\/j.semcancer.2021.06.020"},{"key":"3071_CR24","doi-asserted-by":"publisher","unstructured":"Murtuza A, Bulbul A, Shen JP, Keshavarzian P, Woodward BD, Lopez-Diaz FJ, ... Husain H (2019) Novel third-generation EGFR tyrosine kinase inhibitors and strategies to overcome therapeutic resistance in lung cancer. Cancer Res 79(4):689\u2013698. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1281","DOI":"10.1158\/0008-5472.CAN-18-1281"},{"key":"3071_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","volume":"35","author":"M Nikolaou","year":"2018","unstructured":"Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E (2018) The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metas 35:309\u2013318. https:\/\/doi.org\/10.1007\/s10585-018-9903-0","journal-title":"Clin Exp Metas"},{"key":"3071_CR26","doi-asserted-by":"publisher","unstructured":"Oh B, Kim J, Lu W, Rosenthal D (2014) Anticancer effect of fucoidan in combination with tyrosine kinase inhibitor lapatinib. Evid Based Complement Alternat Med 2014. https:\/\/doi.org\/10.1155\/2014\/865375","DOI":"10.1155\/2014\/865375"},{"issue":"6","key":"3071_CR27","doi-asserted-by":"publisher","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri E, Santoro MM (2016) ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis 7(6):e2253\u2013e2253","journal-title":"Cell Death Dis"},{"issue":"2","key":"3071_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7150\/ijms.1.101","volume":"1","author":"MK Paul","year":"2004","unstructured":"Paul MK, Mukhopadhyay AK (2004) Tyrosine kinase\u2013role and significance in cancer. Int J Med Sci 1(2):101. https:\/\/doi.org\/10.7150\/ijms.1.101","journal-title":"Int J Med Sci"},{"issue":"6\u20137","key":"3071_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11082-011-9540-1","volume":"44","author":"A Rahnama","year":"2012","unstructured":"Rahnama A, Gharagozlou M (2012) Preparation and properties of semiconductor CuO nanoparticles via a simple precipitation method at different reaction temperatures. Opt Quant Electron 44(6\u20137):313\u2013322. https:\/\/doi.org\/10.1007\/s11082-011-9540-1","journal-title":"Opt Quant Electron"},{"key":"3071_CR30","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00432-017-2464-9","volume":"143","author":"MH Raza","year":"2017","unstructured":"Raza MH, Siraj S, Arshad A, Waheed U, Aldakheel F, Alduraywish S, Arshad M (2017) ROS-modulated therapeutic approaches in cancer treatment. J Cancer Res Clin Oncol 143:1789\u20131809. https:\/\/doi.org\/10.1007\/s00432-017-2464-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"3071_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.biopha.2017.02.101","volume":"89","author":"D Rehana","year":"2017","unstructured":"Rehana D, Mahendiran D, Kumar RS, Rahiman AK (2017) Evaluation of antioxidant and anticancer activity of copper oxide nanoparticles synthesized using medicinally important plant extracts. Biomed Pharmacother 89:1067\u20131077. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.101","journal-title":"Biomed Pharmacother"},{"key":"3071_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/annonc\/mdj121","volume":"17","author":"BM Ryan","year":"2006","unstructured":"Ryan BM, Konecny GE, Kahlert S, Wang HJ, Untch M, Meng G, Pegram MD, Podratz KC, Crown J, Slamon DJ, Duffy MJ (2006) Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol 17:597\u2013604. https:\/\/doi.org\/10.1093\/annonc\/mdj121","journal-title":"Ann Oncol"},{"key":"3071_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.msec.2014.08.030","volume":"44","author":"R Sankar","year":"2014","unstructured":"Sankar R, Maheswari R, Karthik S, Shivashangari KS, Ravikumar V (2014) Anticancer activity of Ficus religiosa engineered copper oxide nanoparticles. Mater Sci Eng C 44:234\u2013239. https:\/\/doi.org\/10.1016\/j.msec.2014.08.030","journal-title":"Mater Sci Eng C"},{"issue":"12","key":"3071_CR34","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1016\/j.matpr.2022.04.199","volume":"62","author":"S Sehgal","year":"2022","unstructured":"Sehgal S, Kumar J, Nishtha (2022) Involvement of gold and silver nanoparticles in lung cancer nanomedicines: a review. Mater Today Proc 62(12):6468\u20136476. https:\/\/doi.org\/10.1016\/j.matpr.2022.04.199","journal-title":"Mater Today Proc"},{"issue":"6","key":"3071_CR35","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10876-018-1424-0","volume":"29","author":"SAS Shandiz","year":"2018","unstructured":"Shandiz SAS, Montazeri A, Abdolhosseini M, Shahrestani SH, Hedayati M, Moradi-Shoeili Z, Salehzadeh A (2018) Functionalization of Ag nanoparticles by glutamic acid and conjugation of Ag@ Glu by thiosemicarbazide enhances the apoptosis of human breast cancer MCF-7 cells. J Cluster Sci 29(6):1107\u20131114. https:\/\/doi.org\/10.1007\/s10876-018-1424-0","journal-title":"J Cluster Sci"},{"key":"3071_CR36","doi-asserted-by":"crossref","unstructured":"Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2021) Engineered nanoparticles for drug delivery in cancer therapy. Nanomater Neoplasms 31\u2013142","DOI":"10.1201\/9780429027819-2"},{"issue":"3","key":"3071_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"3071_CR38","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1038\/onc.2011.111","volume":"30","author":"J Tanizaki","year":"2011","unstructured":"Tanizaki J, Okamoto I, Fumita S, Okamoto W, Nishio K, Nakagawa K (2011) Roles of BIM induction and survivin downregulation in lapatinibinduced apoptosis in breast cancer cells with HER2 amplification. Oncogene 30:4097\u20134106. https:\/\/doi.org\/10.1038\/onc.2011.111","journal-title":"Oncogene"},{"issue":"3","key":"3071_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1154\/1.3187152","volume":"24","author":"P Varlashkin","year":"2009","unstructured":"Varlashkin P (2009) X-ray powder diffraction data of lapatinib ditosylate monohydrate. Powder Diffr 24(3):250\u2013253","journal-title":"Powder Diffr"},{"key":"3071_CR40","doi-asserted-by":"publisher","unstructured":"Voigtlaender M, Schneider-Merck T, Trepel M (2018) Lapatinib. Small Mol Oncol 19\u201344. https:\/\/doi.org\/10.1007\/978-3-319-91442-8_2","DOI":"10.1007\/978-3-319-91442-8_2"},{"issue":"8","key":"3071_CR41","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1021\/mp400687w","volume":"11","author":"H Wang","year":"2014","unstructured":"Wang H, Li F, Du C, Wang H, Mahato RI, Huang Y (2014) Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer. Mol Pharm 11(8):2600\u20132611","journal-title":"Mol Pharm"},{"issue":"5","key":"3071_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z (2017) Epidermal growth factor receptor cell proliferation signaling pathways. Cancers 9(5):52. https:\/\/doi.org\/10.3390\/cancers9050052","journal-title":"Cancers"},{"key":"3071_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jchromb.2015.07.021","volume":"1000","author":"L Willmann","year":"2015","unstructured":"Willmann L, Schlimpert M, Halbach S, Erbes T, Stickeler E, Kammerer B (2015) Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines. J Chromatogr B 1000:95\u2013104. https:\/\/doi.org\/10.1016\/j.jchromb.2015.07.021","journal-title":"J Chromatogr B"},{"issue":"1","key":"3071_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/10717544.2022.2039804","volume":"29","author":"JJ Xu","year":"2022","unstructured":"Xu JJ, Zhang WC, Guo YW, Chen XY, Zhang YN (2022) Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Delivery 29(1):664\u2013678. https:\/\/doi.org\/10.1080\/10717544.2022.2039804","journal-title":"Drug Delivery"},{"key":"3071_CR45","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/1535-7163.MCT-08-0168","volume":"7","author":"D Zhang","year":"2008","unstructured":"Zhang D, Pal A, Bornmann WG, Yamasaki F, Esteva FJ, Hortobagyi GN, Bartholomeusz C, Ueno NT (2008) Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells. Mol Cancer Ther 7:1846\u20131850. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0168","journal-title":"Mol Cancer Ther"},{"key":"3071_CR46","doi-asserted-by":"publisher","unstructured":"Zughaibi TA, Mirza AA, Suhail M, Jabir NR, Zaidi SK, Wasi S, ... Tabrez S. (2022) Evaluation of anticancer potential of biogenic copper oxide nanoparticles (CuO NPs) against breast cancer. J Nanomater 2022:1\u20137. https:\/\/doi.org\/10.1155\/2022\/5326355","DOI":"10.1155\/2022\/5326355"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03071-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:06:38Z","timestamp":1727186798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03071-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3071"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03071-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval for human experiments"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}